Clinical Trial Update: A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants [Phase 1]

View source ↗

Summary

Clinical Trial Update on LY3372993 in participants with Alzheimer's disease and healthy volunteers. The Phase 1 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LY3372993

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alzheimer Disease, Healthy | Phase 1 | Status: COMPLETED